David Charles Lubner

BRVE

David Charles Lubner serves as director at BRVE (BRVE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1000.0K

Total Sells

1 trades

$450.0K

Net Position

Net Buyer

$550.0K

Companies Traded

BRVE, ACLX

Active Period

Jan 2026 – Aug 2026

2 total trades

Most Recent

Buy BRVE

Aug 7, 2026 · $1000.0K

David Charles Lubner's Insider Trading at BRVE (BRVE)

Buys

1 · $1000.0K

Sells

0 · $0.00

Total Shares Bought

55,555

Total Shares Sold

BRVE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 7, 2026	Buy	55,555	$18.00	$1000.0K	55,555

David Charles Lubner's Insider Trading at Arcellx, Inc. (ACLX)

Buys

0 · $0.00

Sells

1 · $450.0K

Total Shares Bought

Total Shares Sold

6,000

ACLX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 20, 2026	Sell	6,000	$75.00	$450.0K	0

Related Insiders

AH Bio Fund IV, L.P.

10 percent owner

BRVEBuy · Aug 11, 2026

Erez Chimovits

director, 10 percent owner:

BRVEBuy · Aug 11, 2026

ORBIMED ADVISORS LLC

director, 10 percent owner:

BRVEBuy · Aug 11, 2026

Christopher Viehbacher

director

BRVEBuy · Aug 7, 2026

Michele A. Anderson

officer: Chief Development Officer

BRVEBuy · Aug 7, 2026

Forbion Growth Opportunities Fund III Cooperatief U.A.

10 percent owner

BRVEBuy · Aug 7, 2026

David I Malek

director

BRVEBuy · Aug 7, 2026

Travis Murdoch

director, officer: CEO and President

BRVEBuy · Aug 7, 2026

Explore More Insider Trading Data

BRVE Insider Trading Activity

View all insider trades at BRVE

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity